<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39407204</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>16</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2458</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>15</Day></PubDate></JournalIssue><Title>BMC public health</Title><ISOAbbreviation>BMC Public Health</ISOAbbreviation></Journal><ArticleTitle>Tobacco consumption behavior change during the COVID-19 pandemic is associated with perceived COVID threat.</ArticleTitle><Pagination><StartPage>2827</StartPage><MedlinePgn>2827</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">2827</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12889-024-20259-5</ELocationID><Abstract><AbstractText Label="RATIONALE" NlmCategory="BACKGROUND">Tobacco use is a risk factor for COVID-19 adverse outcomes. Despite health implications, data conflict regarding COVID-19 and tobacco consumption. We present results from a survey of health behaviors during the pandemic to identify how COVID-19 influenced tobacco behaviors.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A nationally administered, internet-based survey was deployed between May-September 2020. Of respondents, we analyzed participants who reported current smoking and/or vaping. Our primary outcome of interest was change in tobacco or vape use using measures from the Behavioral Risk Factor Surveillance System, as well as whether participants reported that these changes were related to COVID-19. Our principal exposures were previously psychometrically evaluated measures of anxiety, depression, and novel perceived COVID-19 threat scale with additional adjustment for age. We employed multinomial logistic regression to determine associations between these factors and tobacco consumption.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified 500 respondents who reported ever smoking in their lifetime, 150 of which reported currently smoking at the time of the survey. Of 220 participants who reported any use of vapes, 110 reported currently vaping. Increased perceived threat of COVID-19 was associated with both increased (aRR<sub>increase</sub> 1.75, 95% CI [1.07-2.86], P = 0.03) and decreased (aRR<sub>decrease</sub> 1.72 [1.04-2.85], P = 0.03) tobacco consumption relative to no change. There were no significant relationships found between perceived threat of COVID-19 and vaping behavior.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">As perceived COVID-19 threat increased, people were more likely to increase or decrease their smoking as opposed to continue at the same amount of use, even after controlling for anxiety and depression, both of which are known to affect smoking in either direction. Further study into motivators of changing tobacco consumption behaviors, and how barriers to care from safer-at-home policies and changes in care delivery moderate change in tobacco use will aid planning tobacco reduction interventions during the ongoing and future respiratory viral pandemics.</AbstractText><AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">This manuscript is derived from baseline survey data obtained in the "Understanding Community Considerations, Opinions, Values, Impacts, and Decisions in COVID-19" study.</AbstractText><AbstractText Label="CLINICALTRIALS" NlmCategory="RESULTS">gov registration NCT04373135, registered 04/30/2020.</AbstractText><CopyrightInformation>© 2024. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Loui</LastName><ForeName>Hollyann F</ForeName><Initials>HF</Initials><AffiliationInfo><Affiliation>Division of Pulmonary &amp; Critical Care Medicine, David Geffen School of Medicine at the University of California, Los Angeles, 1100 Glendon Avenue, Suite 850, Los Angeles, CA, 90024, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Medicine Statistics Core, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Department of Medicine Statistics Core, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Ruby</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine &amp; Health Services Research, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wisk</LastName><ForeName>Lauren E</ForeName><Initials>LE</Initials><AffiliationInfo><Affiliation>Division of General Internal Medicine &amp; Health Services Research, David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Policy and Management, Jonathan and Karin Fielding School of Public Health at the University of California, Los Angeles, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Buhr</LastName><ForeName>Russell G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Division of Pulmonary &amp; Critical Care Medicine, David Geffen School of Medicine at the University of California, Los Angeles, 1100 Glendon Avenue, Suite 850, Los Angeles, CA, 90024, USA. rbuhr@mednet.ucla.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Health Policy and Management, Jonathan and Karin Fielding School of Public Health at the University of California, Los Angeles, CA, USA. rbuhr@mednet.ucla.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for the Study of Healthcare Innovation, Implementation, and Policy, Health Systems Research, Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, CA, USA. rbuhr@mednet.ucla.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT04373135</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>K01 DK116932</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>KL2 TR001882</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>L30 HL134025</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001881</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Public Health</MedlineTA><NlmUniqueID>100968562</NlmUniqueID><ISSNLinking>1471-2458</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>Res Sq. 2023 Jul 06:rs.3.rs-3143401. doi: 10.21203/rs.3.rs-3143401/v1</RefSource><PMID Version="1">37461647</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072137" MajorTopicYN="Y">Vaping</DescriptorName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064424" MajorTopicYN="Y">Tobacco Use</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040343" MajorTopicYN="N">Behavioral Risk Factor Surveillance System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015438" MajorTopicYN="N">Health Behavior</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Mental health</Keyword><Keyword MajorTopicYN="N">Smoking</Keyword><Keyword MajorTopicYN="N">Tobacco</Keyword><Keyword MajorTopicYN="N">Vaping</Keyword></KeywordList><CoiStatement>Dr. Buhr reports prior personal consulting fees for Viatris/Theravance Biopharma, Chiesi, 2ndMD, and DynaMed/American College of Physicians unrelated to this work and is an employee of the Veterans Health Administration. The views and positions in this manuscript do not necessarily reflect those of the Department of Veterans Affairs or United States Government. Drs. Loui, Wisk, and Jackson, Ms. Romero, and Mr. Li report nothing to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>7</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>16</Day><Hour>0</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>23</Hour><Minute>48</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39407204</ArticleId><ArticleId IdType="pmc">PMC11476555</ArticleId><ArticleId IdType="doi">10.1186/s12889-024-20259-5</ArticleId><ArticleId IdType="pii">10.1186/s12889-024-20259-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Patanavanich R, Glantz SA. Smoking Is Associated With COVID-19 Progression: A Meta-analysis. Nicotine Tob Res. 2020;22(9):1653–6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7239135</ArticleId><ArticleId IdType="pubmed">32399563</ArticleId></ArticleIdList></Reference><Reference><Citation>Farsalinos K, Barbouni A, Poulas K, Polosa R, Caponnetto P, Niaura R. Current smoking, former smoking, and adverse outcome among hospitalized COVID-19 patients: a systematic review and meta-analysis. Ther Adv Chronic Dis. 2020;11:2040622320935765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7318805</ArticleId><ArticleId IdType="pubmed">32637059</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker J, Krishnan N, Abroms LC, Berg CJ. The Impact of Tobacco Use on COVID-19 Outcomes: A Systematic Review. J Smok Cessat. 2022;2022:5474397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8777389</ArticleId><ArticleId IdType="pubmed">35126740</ArticleId></ArticleIdList></Reference><Reference><Citation>Bommele J, Hopman P, Walters BH, Geboers C, Croes E, Fong GT, Quah ACK, Willemsen M. The double-edged relationship between COVID-19 stress and smoking: Implications for smoking cessation. Tob Induc Dis. 2020;18:63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7386200</ArticleId><ArticleId IdType="pubmed">32733178</ArticleId></ArticleIdList></Reference><Reference><Citation>Rigotti NA, Chang Y, Regan S, Lee S, Kelley JHK, Davis E, Levy DE, Singer DE, Tindle HA. Cigarette Smoking and Risk Perceptions During the COVID-19 Pandemic Reported by Recently Hospitalized Participants in a Smoking Cessation Trial. J Gen Intern Med. 2021;36(12):3786–93. 10.1007/s11606-021-06913-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8183588</ArticleId><ArticleId IdType="pubmed">34100230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozcelik N, Yilmaz Kara B. Effect of coronaphobia on smoking habits. J Addict Dis. 2021;39(2):241–7.</Citation><ArticleIdList><ArticleId IdType="pubmed">33283686</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho LLK, Li WHC, Cheung AT, Xia W, Wang MP, Cheung DYT, Lam TH. Impact of COVID-19 on the Hong Kong Youth Quitline Service and Quitting Behaviors of Its Users. Int J Environ Res Public Health. 2020;17(22):8397. 10.3390/ijerph17228397.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7696005</ArticleId><ArticleId IdType="pubmed">33202764</ArticleId></ArticleIdList></Reference><Reference><Citation>Carreras G, Lugo A, Stival C, Amerio A, Odone A, Pacifici R, Gallus S, Gorini G. Impact of COVID-19 lockdown on smoking consumption in a large representative sample of Italian adults. Tob Control. 2022;31(5):615–22. 10.1136/tobaccocontrol-2020-056440.</Citation><ArticleIdList><ArticleId IdType="pubmed">33782199</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling PM, Glantz SA. Tobacco industry research on smoking cessation. Recapturing young adults and other recent quitters. J Gen Intern Med. 2004;19(5 (Pt 1)):419–26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1492251</ArticleId><ArticleId IdType="pubmed">15109339</ArticleId></ArticleIdList></Reference><Reference><Citation>Feinberg JR. Smoking through COVID? You’re not alone. New York City: The New York Times; 2020. Available from: https://www.nytimes.com/interactive/2020/10/08/business/covid-smoking-cigarette-sales.html.</Citation></Reference><Reference><Citation>Maloney J. Cigarette Smoking Makes Comeback During Coronavirus Pandemic. New York City: The Wall Street Journal. 2020. https://www.wsj.com/articles/altrias-net-revenue-falls-11595938465.</Citation></Reference><Reference><Citation>Fluharty M, Taylor AE, Grabski M, Munafò MR. The Association of Cigarette Smoking With Depression and Anxiety: A Systematic Review. Nicotine Tob Res. 2017;19(1):3–13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5157710</ArticleId><ArticleId IdType="pubmed">27199385</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandi A, Galea S, Ahern J, Vlahov D. Probable cigarette dependence, PTSD, and depression after an urban disaster: results from a population survey of New York City residents 4 months after September 11, 2001. Psychiatry. 2005;68(4):299–310.</Citation><ArticleIdList><ArticleId IdType="pubmed">16599397</ArticleId></ArticleIdList></Reference><Reference><Citation>Caponnetto P, Inguscio L, Saitta C, Maglia M, Benfatto F, Polosa R. Smoking behavior and psychological dynamics during COVID-19 social distancing and stay-at-home policies: a survey. Health Psychol Res. 2020;8(1):9124.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270632</ArticleId><ArticleId IdType="pubmed">32529094</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisk LE, Buhr RG. Rapid deployment of a community engagement study and educational trial via social media: implementation of the UC-COVID study. Trials. 2021;22(1):513.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8327053</ArticleId><ArticleId IdType="pubmed">34340693</ArticleId></ArticleIdList></Reference><Reference><Citation>California Tobacco Facts and Figures 2022. https://www.cdph.ca.gov/Programs/CCDPHP/DCDIC/CTCB/CDPH%20Document%20Library/ResearchandEvaluation/FactsandFigures/CaliforniaTobaccoFactsAndFigures2022.pdf.</Citation></Reference><Reference><Citation>Smoking &amp; Tobacco Use - Fast Facts &amp; Fact Sheets. https://www.cdc.gov/tobacco/data_statistics/fact_sheets/fast_facts/index.htm.</Citation></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O’Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, et al. The REDCap consortium: Building an international community of software platform partners. J Biomed Inform. 2019;95:103208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377–81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierannunzi C, Hu SS, Balluz L. A systematic review of publications assessing reliability and validity of the Behavioral Risk Factor Surveillance System (BRFSS), 2004–2011. BMC Med Res Methodol. 2013;13:49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3622569</ArticleId><ArticleId IdType="pubmed">23522349</ArticleId></ArticleIdList></Reference><Reference><Citation>Behavioral Risk Factor Surveillance System - Survey Data &amp; Documentation. https://www.cdc.gov/brfss/data_documentation/index.htm.</Citation></Reference><Reference><Citation>Sapra A, Bhandari P, Sharma S, Chanpura T, Lopp L. Using Generalized Anxiety Disorder-2 (GAD-2) and GAD-7 in a Primary Care Setting. Cureus. 2020;12(5):e8224.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7306644</ArticleId><ArticleId IdType="pubmed">32582485</ArticleId></ArticleIdList></Reference><Reference><Citation>Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24–31.</Citation><ArticleIdList><ArticleId IdType="pubmed">26719105</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284–92.</Citation><ArticleIdList><ArticleId IdType="pubmed">14583691</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway LG, Woodard SR, Zubrod A. Social Psychological Measurements of COVID-19: Coronavirus Perceived Threat, Government Response, Impacts, and Experiences Questionnaires. PsyArXiv. 2020. Ithaca, New York, USA. Preprint.</Citation></Reference><Reference><Citation>Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res. 2013;22(3):278–95.</Citation><ArticleIdList><ArticleId IdType="pubmed">21220355</ArticleId></ArticleIdList></Reference><Reference><Citation>W. N. Venables BDR: Modern Applied Statistics with S, Fourth edn. New York: Springer; 2002.</Citation></Reference><Reference><Citation>Wickham H. ggplot2: Elegant Graphics for Data Analysis. 2nd ed. New York: Springer-Verlag; 2016.</Citation></Reference><Reference><Citation>Finney Rutten LJ, Augustson EM, Moser RP, Beckjord EB, Hesse BW. Smoking knowledge and behavior in the United States: sociodemographic, smoking status, and geographic patterns. Nicotine Tob Res. 2008;10(10):1559–70.</Citation><ArticleIdList><ArticleId IdType="pubmed">18946775</ArticleId></ArticleIdList></Reference><Reference><Citation>Battjes RJ. Smoking as an issue in alcohol and drug abuse treatment. Addict Behav. 1988;13(3):225–30.</Citation><ArticleIdList><ArticleId IdType="pubmed">3051913</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA Updates and Press Announcements on Nitrosamine in Varenicline (Chantix). https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-and-press-announcements-nitrosamine-varenicline-chantix.</Citation></Reference><Reference><Citation>Messer K, Trinidad DR, Al-Delaimy WK, Pierce JP. Smoking cessation rates in the United States: a comparison of young adult and older smokers. Am J Public Health. 2008;98(2):317–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2376894</ArticleId><ArticleId IdType="pubmed">18172143</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrington-Trimis JL, Braymiller JL, Unger JB, McConnell R, Stokes A, Leventhal AM, Sargent JD, Samet JM, Goodwin RD. Trends in the Age of Cigarette Smoking Initiation Among Young Adults in the US From 2002 to 2018. JAMA Netw Open. 2020;3(10):e2019022–e2019022.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539122</ArticleId><ArticleId IdType="pubmed">33021650</ArticleId></ArticleIdList></Reference><Reference><Citation>Wisk LE, Nelson EB, Magane KM, Weitzman ER. Clinical Trial Recruitment and Retention of College Students with Type 1 Diabetes via Social Media: An Implementation Case Study. J Diabetes Sci Technol. 2019;13(3):445–56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6501540</ArticleId><ArticleId IdType="pubmed">31010315</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>